CLASS II Device recall · Reported 7 Jun 2017 · FDA Enforcement Report

Angio WorkStation (Xidf-AWS801) used in conjunction recalled

Toshiba American Medical Systems is recalling Angio WorkStation (Xidf-AWS801) used in conjunction with your Infinix System, distributed in 28 states. The recall was initiated on 1 Feb 2017 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesS/N : 8181622393
Quantity recalledUS - 70 systems

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-2109-2017
FDA event ID
77195
Recalling firm
Toshiba American Medical Systems, Tustin, CA
Classification
Class II
Status
Terminated
Recall initiated
1 Feb 2017
FDA classified
30 May 2017
Reported
7 Jun 2017
Type
FDA Mandated
Customers notified by
Letter
Reason category
Other Reasons

Timeline

1 Feb 2017Recall initiated by company
30 May 2017Classified by FDA+118 days
7 Jun 2017Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

It was found that during a procedure the Peak Skin Dose (PSD) value displayed by the Dose Tracking System (DTS) was larger than the DTS expected value. This issue occurs when the power for the Angio Workstation is turned on after the power for the Infinix system is turned on.

Product as listed by the FDA

Angio WorkStation (XIDF-AWS801) used in conjunction with your Infinix System (INFX-8000V;INFX-8000C;INFX-8000F

Where it was distributed

US Distribution to the states of :LA, IL, NY, FL, MA, TN, MO, GA, CA, DE, MO, AL, ID, MN, TX, CT, PA, MS, OH, NC, NV, W VA, WA, AR, NJ, MD, OK, IN and NH.

AlabamaArkansasCaliforniaConnecticutDelawareFloridaGeorgiaIdahoIllinoisIndianaLouisianaMassachusettsMarylandMinnesotaMissouriMississippiNorth CarolinaNew HampshireNew JerseyNevada

Questions about this recall

Why was it recalled?

It was found that during a procedure the Peak Skin Dose (PSD) value displayed by the Dose Tracking System (DTS) was larger than the DTS expected value. This issue occurs when the power for the Angio Workstation is turned on after the power for the Infinix system is turned on.

Which lots are affected?

S/N : 8181622393

Where was it sold?

US Distribution to the states of :LA, IL, NY, FL, MA, TN, MO, GA, CA, DE, MO, AL, ID, MN, TX, CT, PA, MS, OH, NC, NV, W VA, WA, AR, NJ, MD, OK, IN and NH.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Toshiba American Medical Systems

All 57

Other Other Medical Devices recalls

All 13,778